|
AARCMC is pleased to offer
a screening test for Alpha-1 Antitrypsin Deficiency.
This is an under recognized disorder that can involve
the lungs, liver and less commonly skin. Deficiency of
Alpha-1 Antitrypsin predisposes to chronic obstructive
pulmonary disease or emphysema.
Patients should be
considered for screening if they have any of the
following:
- Early onset
pulmonary emphysema (age 45 years or less)
- Emphysema
prominent in the lower lobes
- Emphysema in the
absence of recognized risk factors such as smoking
or occupational dust exposure.
- Family history of
AAT deficiency, emphysema, bronchiectasis, liver
disease or panniculitis
- Shortness of
breath or cough in multiple family members
- Liver disease of
unknown cause
- Adults with
bronchiectasis without evident etiology
- Patients with
asthma whose spirometry fails to return to normal
with therapy
- Unexplained
panniculitis(skin disorder) and anti-proteinase 3
vasculitis(Wegener’s granulomatosis)
If you are interested
or need further information, please contact one of the
health care providers at AARCMC. The screening test
portion of the visit will be complimentary.
|